Provided by Tiger Trade Technology Pte. Ltd.

ArTara Therapeutics, Inc.

5.46
+0.14002.63%
Volume:300.07K
Turnover:1.64M
Market Cap:295.30M
PE:-4.07
High:5.55
Open:5.32
Low:5.32
Close:5.32
52wk High:7.82
52wk Low:2.77
Shares:54.08M
Float Shares:35.46M
Volume Ratio:0.63
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3409
EPS(LYR):-1.3409
ROE:-31.60%
ROA:-20.64%
PB:1.50
PE(LYR):-4.07

Loading ...

Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 30, 2026

Major Issues Report

Form 8-K - Current report
Mar 10, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2026

Major Issues Report

Form 8-K - Current report
Mar 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Major Issues Report

Form 8-K - Current report
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans